プレスリリース

Illumina to Present at Upcoming Investment Conferences in March

SAN DIEGO, Mar 02, 2011 (BUSINESS WIRE) --

Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentations at two upcoming investment conferences.

Illumina will webcast its presentation at the Cowen Health Care Conference in Boston, Massachusetts, on March 9, 2011. The live webcast is scheduled to begin at 8:45 a.m. ET and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer, followed by a question and answer session.

Illumina will also webcast its presentation at the Barclays Capital Global Healthcare Conference in Miami, Florida, on March 15, 2011. The live webcast is scheduled to begin at 3:15 p.m. ET and will feature an overview of the company by Christian Henry, Senior Vice President, Chief Financial Officer and General Manager of Life Sciences, followed by a question and answer session.

These live webcasts can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com.

About Illumina

Illumina (http://www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.

SOURCE: Illumina, Inc.

Illumina, Inc.
Investors:
Peter J. Fromen
Sr. Director, Investor Relations
+858-202-4507
pfromen@illumina.com
or
Media:
Wilson Grabill
Sr. Manager, Public Relations
+858-882-6822
wgrabill@illumina.com

Recent Articles

大塚製薬株式会社が日本初の保険適用された造血器腫瘍遺伝子パネル検査を発売
大塚製薬株式会社が日本初の保険適用された造血器腫瘍遺伝子パネル検査を発売
研究により、未選択の脳性麻痺の相当な遺伝的起源が明らかになりました
研究により、未選択の脳性麻痺の相当な遺伝的起源が明らかになりました
イルミナのシンガポールチームががんと闘う
イルミナのシンガポールチームががんと闘う